CH335488A - Process for the manufacture of a 14-oxy-steroid - Google Patents
Process for the manufacture of a 14-oxy-steroidInfo
- Publication number
- CH335488A CH335488A CH335488DA CH335488A CH 335488 A CH335488 A CH 335488A CH 335488D A CH335488D A CH 335488DA CH 335488 A CH335488 A CH 335488A
- Authority
- CH
- Switzerland
- Prior art keywords
- sep
- fungus
- dione
- steroid
- oxy
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 7
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 241000233866 Fungi Species 0.000 claims description 7
- 230000003647 oxidation Effects 0.000 claims description 4
- 238000007254 oxidation reaction Methods 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 241001450870 Thamnostylum piriforme Species 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 claims description 2
- 230000004151 fermentation Effects 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 239000002904 solvent Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000013078 crystal Substances 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001450823 Helicostylum Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 229960005471 androstenedione Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229950011333 edamine Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/06—Hydroxylating
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Zusatzpatent zum Hauptpatent Nr. 329194 Verfahren zur Herstellung eines 14-Oxy-steroids Die Erfindung bezieht sich auf die Her stellung eines neuen Steroids, das 14a,17a,21- Trioxy-4-pregnen-3,20-dion aus 17a,21-Dioxy- 4-pregnen-3,20-dion oder dessen 21-Acylester durch biochemische Oxydation mit Enzymen, die von einem Pilz der Gattung Helicostyhtm, welche der Ordnung l@Iucorales angehört, z. B.
Helicostylum piriforme, erzeugt werden. Es können die isolierten Enzyme der Pilze ver wendet werden. Das bevorzugte Verfahren be steht aber darin, die Oxydation unter F'ermen- tationsbedingungen unter Verwendung eines lebensfähigen Pilzes in Gegenwart einer Nähr lösung zu leiten und hernach das oxydierte- Steroid abzutrennen, wie im folgenden Bei spiel eingehend erläutert wird.
Das 7.4a,17a,21-Trioxy-4-pregneii-3,20-dion, das pharmakologische Wirkung zeigt, kann mit (",hromt.rioxyd zu 14a-Oxy-4-androsten- 3,17-dion mit einem Schmelzpunkt j-on 259 bis 263 C oxydiert werden.
Beispiel. Es wurde ein Nährmedium aus 20 g Lact- < il biiminauszug ( E damin , enzy mat.ischer Lact- albuminauszug), 3 g Maisquellwasser und 50 g technischer Dextrose verdünnt in einem Liter Leitungswasser, und auf einen 1),1-Wert von 4,3 bis 4,5 gebracht, hergestellt..
12 Liter des Sterilisierten Nährmediums wurden mit Heli- eostyliim piriforme-Sporen (ATCC Nr. 8992) beimpft. und 24 Stunden bei einer Tempera tur von 28 C unter Belüftung und Rühren bebrütet, so dass die Sauerstoffaufnahme 6,3 bis 7 Millimol pro Liter und Stunde von Na2803 entsprechend der Methode von Cooper, Fernstrom und Miller, Ind. Eng. Chem. 36, 504 (1944) betrug.
Zu diesem Medium, wel ches eine 24 Stunden alte Kultur von Heli- costylum piriforme enthielt, wurden 2 g der Verbindung S von Reichstein [17a,21-Dioxy-4- pregnen-3,20-dion] in einem Minimum von Äthanol hinzugefügt, um eine Suspension des Steroids in der Kultur zu erhalten. Nach einer weiteren Brutperiode von 24 Stunden unter denselben Temperatur- und Belüftungsbedin gungen wurde die Würze und das Mycel extra hiert.
Das Mycel wurde abfiltriert und zwei mal in je einem annähernd der Mycelmenge entsprechenden Volumen Aceton gewaschen und dann zweimal finit einem annähernd der Mycelmenge entsprechenden Volumen Methy- lenchlorid extrahiert. Die Aceton- und Methy- lenchloridextrakte wurden einschliesslich des Lösungsmittels dein Würzefiltrat zugesetzt.
Die gemischten Extrakte und die 'VGrürzefil- trate wurden nach und nach mit zwei ihrem halben Volumen entsprechenden Volumen Me- thylenchlorid und hierauf finit zwei einem Viertel ihres Volumens entsprechenden Volu men Methylenchlorid extrahiert.
Die vereinig- teil ;1Iethylcncllloridetrakte wurden mit zwei einem Zehntel ihres Volumens entsprechenden Teilen einer 2 % igen wässrigen Natriumbicar- bonatlösung und hierauf mit zwei einem Zehn tel ihres Volumens entsprechenden Teilen Wasser gewaschen.
Nach Trocknung der Me- thylenchloridextrakte mit ungefähr 3-5 g wasserfreiem Natriumsulfat pro Liter Lö sungsmittel und Abfiltrieren wurde das Lö sungsmittel durch Destillation entfernt.. Der Rückstand wurde in einem Minimum 12ethv- lenehlorid gelöst, filtriert und das Lösungs- mittel verdampft. Die entstehenden Rohkri stalle wurden getrocknet und dann fünfmal mit. je 5 em3 Äther pro Gramm Rohkristalle gewaschen. Iss ergab sich ein Rückstand von 4,354 g.
Der Rückstand wurde in 10 em3 Äthylendichlorid gelöst und über 350 g Florisil , einem synthetischen Magnesiumsili- kat, unter Verwendung von 550-cm3-Portionen von E,ntwieklungs - Lösungsmittelfraktionen gemäss Tabelle chromatographiert.
EMI0002.0031
<I>Tabelle</I>
<tb> Helicostylum <SEP> piriforme
<tb> Fraktion <SEP> Lösungsmittel <SEP> Ausbeute <SEP> in <SEP> mg
<tb> 1. <SEP> Ä <SEP> thylendichlorid <SEP> 479,5
<tb> 2 <SEP> Äthylendichlorid <SEP> 403,0
<tb> 3 <SEP> Äthylendichlorid-Aeeton <SEP> 15:
1 <SEP> 815,5
<tb> 4 <SEP> <SEP> <B>15:1</B> <SEP> 36,5
<tb> 5 <SEP> <SEP> 12:1 <SEP> 36,0
<tb> 6 <SEP> <SEP> 12:1. <SEP> 50,0
<tb> 7 <SEP> <SEP> 12:1 <SEP> 109,5
<tb> 8 <SEP> <SEP> <B>10:1</B> <SEP> 159,0
<tb> 9 <SEP> <SEP> <B>10:1</B> <SEP> 148,0
<tb> 10 <SEP> <SEP> <B>8:1</B> <SEP> 145,0
<tb> 11 <SEP> <SEP> <B>8:1</B> <SEP> 104,5
<tb> 12 <SEP> <SEP> <B>8:1</B> <SEP> 98,0
<tb> 13 <SEP> <SEP> <B>5:</B> <SEP> 1. <SEP> 170,0
<tb> 14 <SEP> <SEP> <B>5:1-</B> <SEP> 123,0
<tb> 15 <SEP> <SEP> :1 <SEP> 123,5
<tb> 16 <SEP> <SEP> <I>3:1</I> <SEP> 1.27,5
<tb> 17 <SEP> <SEP> <B>3:1</B> <SEP> 200,0
<tb> 1.8 <SEP> <SEP> 1. <SEP> :1 <SEP> 456,0
<tb> 19 <SEP> <SEP> 1 <SEP> :
1 <SEP> 356,0
<tb> 20 <SEP> Aceton <SEP> 226,5 Die Fraktionen 13-16 inklusive, befreit vom Lösungsmittel, wurden aus 10 cm3 Äther umkristallisiert, indem der Äther langsam bei Zimmertemperatur verdampft wurde. Die Kri stallisation brachte 228,6 mg Kristalle mit einem .Schmelzpunkt von 218 bis 2261' C. Zwei weitere Umkristallisationen, jede aus 10 em3 Äther-Aceton im Verhältnis 1 :1 gewonnen, ergaben Kristalle mit einem Schmelzpunkt von 232 bis 235 C.
Die Umkristallisation einer Probe dieser Substanz, 5 7 mg, aus 5 cm3 Methanol ergab 14a,17a,21-Trioxy-4-pregnen- 3,20-dion mit einem Schmelzpunkt von 234 bis 237a C, [a] D + 155 (c =1,13 in Methanol) mit einem einheitlichen Infrarotspektrum. Analyse : /o berechnet für C2111300,5 : C = 69,58 1I = 8,34 o/0 gefunden: C . = 69.42 11 = 8,40 Die Verwendung eines 21-Aeylesters, z. B.
des Acetats, bringt dieselben Ergebnisse.
Additional patent to the main patent No. 329194 Process for the production of a 14-oxy-steroid The invention relates to the production of a new steroid, the 14a, 17a, 21-trioxy-4-pregnen-3,20-dione from 17a, 21- Dioxy-4-pregnen-3,20-dione or its 21-acyl ester by biochemical oxidation with enzymes produced by a fungus of the genus Helicostyhtm, which belongs to the order l @ Iucorales, e.g. B.
Helicostylum piriforme. The isolated enzymes of the fungi can be used. The preferred method, however, consists in conducting the oxidation under fermentation conditions using a viable fungus in the presence of a nutrient solution and then separating off the oxidized steroid, as will be explained in detail in the following example.
The 7.4a, 17a, 21-trioxy-4-pregneii-3,20-dione, which shows pharmacological effects, can be mixed with (", chromium oxide to 14a-oxy-4-androstene-3,17-dione with a melting point j-on 259 to 263 C are oxidized.
Example. A nutrient medium consisting of 20 g of lactic acid (edamine, enzymatic lactic albumin extract), 3 g of corn steep liquor and 50 g of technical dextrose was diluted in one liter of tap water, and to a 1), 1 value of 4 , 3 to 4.5 brought, manufactured ..
12 liters of the sterilized culture medium were inoculated with Helieostyliim piriforme spores (ATCC No. 8992). and incubated for 24 hours at a temperature of 28 C with aeration and stirring, so that the oxygen uptake is 6.3 to 7 millimoles per liter and hour of Na2803 according to the method of Cooper, Fernstrom and Miller, Ind. Eng. Chem. 36, 504 (1944).
To this medium, which contained a 24 hour old culture of Helicostylum piriforme, 2 g of the compound S from Reichstein [17a, 21-Dioxy-4-pregnen-3,20-dione] in a minimum of ethanol were added, to obtain a suspension of the steroid in the culture. After a further incubation period of 24 hours under the same temperature and ventilation conditions, the wort and mycelium were extracted.
The mycelium was filtered off and washed twice in a volume of acetone each approximately corresponding to the amount of mycelium and then finitely extracted twice with a volume of methylene chloride approximately corresponding to the amount of mycelium. The acetone and methylene chloride extracts, including the solvent, were added to the wort filtrate.
The mixed extracts and the spice filtrates were gradually extracted with two volumes of methylene chloride corresponding to half their volume and then finitely two volumes of methylene chloride corresponding to one quarter of their volume.
The combined methylene chloride tracts were washed with two parts corresponding to one-tenth of their volume of a 2% strength aqueous sodium bicarbonate solution and then with two parts of water corresponding to one-tenth of their volume.
After drying the methylene chloride extracts with about 3-5 g of anhydrous sodium sulfate per liter of solvent and filtering them off, the solvent was removed by distillation. The residue was dissolved in a minimum of 12 ethylene chloride, filtered and the solvent evaporated. The resulting Rohkri stalle were dried and then five times with. washed 5 em3 ether per gram of raw crystals. There was a residue of 4.354 g.
The residue was dissolved in 10 cubic meters of ethylene dichloride and chromatographed over 350 g of Florisil, a synthetic magnesium silicate, using 550 cm3 portions of weight-bearing solvent fractions according to the table.
EMI0002.0031
<I> table </I>
<tb> Helicostylum <SEP> piriforme
<tb> Fraction <SEP> Solvent <SEP> Yield <SEP> in <SEP> mg
<tb> 1. <SEP> Ä <SEP> ethylene dichloride <SEP> 479.5
<tb> 2 <SEP> ethylene dichloride <SEP> 403.0
<tb> 3 <SEP> ethylene dichloride-aeetone <SEP> 15:
1 <SEP> 815.5
<tb> 4 <SEP> <SEP> <B> 15: 1 </B> <SEP> 36.5
<tb> 5 <SEP> <SEP> 12: 1 <SEP> 36.0
<tb> 6 <SEP> <SEP> 12: 1. <SEP> 50.0
<tb> 7 <SEP> <SEP> 12: 1 <SEP> 109.5
<tb> 8 <SEP> <SEP> <B> 10: 1 </B> <SEP> 159.0
<tb> 9 <SEP> <SEP> <B> 10: 1 </B> <SEP> 148.0
<tb> 10 <SEP> <SEP> <B> 8: 1 </B> <SEP> 145.0
<tb> 11 <SEP> <SEP> <B> 8: 1 </B> <SEP> 104.5
<tb> 12 <SEP> <SEP> <B> 8: 1 </B> <SEP> 98.0
<tb> 13 <SEP> <SEP> <B> 5: </B> <SEP> 1. <SEP> 170.0
<tb> 14 <SEP> <SEP> <B> 5: 1- </B> <SEP> 123.0
<tb> 15 <SEP> <SEP>: 1 <SEP> 123.5
<tb> 16 <SEP> <SEP> <I> 3: 1 </I> <SEP> 1.27.5
<tb> 17 <SEP> <SEP> <B> 3: 1 </B> <SEP> 200.0
<tb> 1.8 <SEP> <SEP> 1. <SEP>: 1 <SEP> 456.0
<tb> 19 <SEP> <SEP> 1 <SEP>:
1 <SEP> 356.0
<tb> 20 <SEP> acetone <SEP> 226.5 Including fractions 13-16, freed from the solvent, were recrystallized from 10 cm3 of ether by slowly evaporating the ether at room temperature. The crystallization produced 228.6 mg of crystals with a melting point of 218 to 2261 ° C. Two further recrystallizations, each obtained from 10 em3 of ether-acetone in a ratio of 1: 1, gave crystals with a melting point of 232 to 235 C.
Recrystallization of a sample of this substance, 57 mg, from 5 cm3 of methanol gave 14a, 17a, 21-trioxy-4-pregnene-3,20-dione with a melting point of 234 to 237a C, [a] D + 155 (c = 1.13 in methanol) with a uniform infrared spectrum. Analysis: / o calculated for C2111300.5: C = 69.58 1I = 8.34 o / 0 found: C. = 69.42 11 = 8.40 The use of a 21-ethyl ester, e.g. B.
of acetate gives the same results.
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US335488XA | 1952-02-23 | 1952-02-23 | |
| CH329194T | 1953-11-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH335488A true CH335488A (en) | 1958-12-31 |
Family
ID=25736558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH335488D CH335488A (en) | 1952-02-23 | 1952-07-08 | Process for the manufacture of a 14-oxy-steroid |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH335488A (en) |
-
1952
- 1952-07-08 CH CH335488D patent/CH335488A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH335488A (en) | Process for the manufacture of a 14-oxy-steroid | |
| DE948686C (en) | Process for the preparation of 4-pregnen-14ª ‡, 17ª ‡, 21-triol-3,20-dione | |
| DE937228C (en) | Process for the preparation of 4-androsten-8-ol-3, 17-dione | |
| DE937056C (en) | Process for the preparation of 5-pregnen-3ª ‰, 7ª ‡, 11ª ‡ -triol-20-one | |
| CH334920A (en) | Process for the preparation of a trioxypregnene derivative | |
| DE1000023C2 (en) | Process for the preparation of 4-pregnen-17ª ‡ -ol-3, 6, 20-trione | |
| CH385204A (en) | Process for making steroid compounds | |
| CH333720A (en) | Process for the production of 11a, 17a-dioxy-progesterone | |
| CH335489A (en) | Process for the production of a progesterone derivative | |
| DE1904543C3 (en) | Process for the microbiological conversion of 3 ß-hydroxy-5,6-epoxy steroids into 6-hydroxy-3-keto-A4 steroids | |
| DE730908C (en) | Process for the preparation of unsaturated ketones of the cyclopentanopolyhydrophenanthrene series by biochemical means | |
| DE951444C (en) | Process for the preparation of 4-pregnen-8, 17ª ‡, 21-triol-3, 20-dione | |
| AT212498B (en) | Process for the microbiological oxidation of steroids | |
| DE956510C (en) | Process for the production of 14ª ‡ -oxytestosterone or 14ª ‡ -oxy-10-normethyltestosterone | |
| AT235476B (en) | Process for the preparation of the new 11β, 21-dihydroxy-16α-alkyl-4,17 (20) -pregnadien-3-ones | |
| DE1027667B (en) | Process for the production of polyoxygenated pregnanes | |
| CH331974A (en) | Process for the preparation of unsaturated 17-keto-steroids | |
| DE1070176B (en) | Process for the production of new steroid compounds of the 1, 4 - Pregnadiene series | |
| EP0217840A1 (en) | PROCESS FOR THE PRODUCTION OF 1-METHYL-1,4-ANDROSTADIENE-3,17-DIONE. | |
| CH334829A (en) | Process for the preparation of an 11-oxy-steroid | |
| DE955058C (en) | Process for the production of 14ª ‡ -oxyprogesterone | |
| CH308138A (en) | Method of making a steroid compound. | |
| CH349978A (en) | Process for the microbiological 1-dehydration of steroids | |
| CH334919A (en) | Process for the production of a dioxyprogesterone | |
| CH335490A (en) | Process for the production of cholenic derivatives |